Organic Letters
Letter
(9) For recent examples on synthetic applications of α-sulfonyl
ketones by the authors, see: (a) Chang, M.-Y.; Cheng, Y.-C.; Lu, Y.-J.
Org. Lett. 2014, 16, 6252−6255. (b) Chang, M.-Y.; Cheng, Y.-C.; Lu,
Y.-J. Org. Lett. 2015, 17, 1264−1267. (c) Chang, M.-Y.; Cheng, Y.-C.;
Lu, Y.-J. Org. Lett. 2015, 17, 3142−3145. (d) Chang, M.-Y.; Cheng,
Y.-C. Org. Lett. 2015, 17, 5702−5705. (e) Chang, M.-Y.; Cheng, Y.-C.
Org. Lett. 2016, 18, 608−611. (f) Chang, M.-Y.; Cheng, Y.-C. Org.
Lett. 2016, 18, 1682−1685. (g) Chang, M.-Y.; Tsai, C.-Y. Tetrahedron
Lett. 2014, 55, 5548−5550.
Lett. 2011, 13, 4514−4517. (f) Vidal-Albalat, A.; Rodriguez, S.;
́
Gonzalez, F. V. Org. Lett. 2014, 16, 1752−1755. (g) Wu, D.; Zhang,
J.; Cui, J.; Zhang, W.; Liu, Y. Chem. Commun. 2014, 50, 10857−
10860.
(21) For examples on biological activities of quinoxalines, see:
(a) Kotharkar, S. A.; Shinde, D. B. Bioorg. Med. Chem. Lett. 2006, 16,
6181−6184. (b) Rodrigues, F. A. R.; Bomfim, I. S.; Cavalcanti, B. C.;
Pessoa, C. O.; Wardell, J. L.; Wardell, S. M. S. V.; Pinheiro, A. C.;
Kaiser, C. R.; Nogueira, T. C. M.; Low, J. N.; Gomes, L. R.; de Souza,
M. V. N. Bioorg. Med. Chem. Lett. 2014, 24, 934−939. (c) Parhi, A. K.;
Zhang, Y.; Saionz, K. W.; Pradhan, P.; Kaul, M.; Trivedi, K.; Pilch, D.
S.; LaVoie, E. J. Bioorg. Med. Chem. Lett. 2013, 23, 4968−4974.
(10) For synthesis of bis-sulfonyl skeletons, see: (a) Bin, K.; Lee, J.
̈
S.; Kim, K. Org. Lett. 2004, 6, 4297−4300. (b) Vogtle, F.;
Fakhrnabavi, H.; Lukin, O. Org. Lett. 2004, 6, 1075−1078.
(c) Viso, A.; de la Pradilla, R. F.; Urena, M.; Colomer, I. Org. Lett.
̃
2008, 10, 4775−4778. (d) Zhang, J.; Shao, Y.; Wang, H.; Luo, Q.;
Chen, J.; Xu, D.; Wan, X. Org. Lett. 2014, 16, 3312−3315. (e) Yan,
X.; Ling, F.; Zhang, Y.; Ma, C. Org. Lett. 2015, 17, 3536−3539. (f) Fu,
H.; Shang, J. Q.; Yang, T.; Shen, Y.; Gao, C.-Z.; Li, Y.-M. Org. Lett.
2018, 20, 489−492. (g) Petroff, J. T., II; Skubic, K. N.; Arnatt, C. K.;
McCulla, R. D. J. Org. Chem. 2018, 83, 14063−14068.
(11) Reviews on DMSO-mediated reactions, see: (a) Xiao, W.-J.
Solvents as Reagents in Organic Synthesis: Reactions and Applications;
Xiang, J.-C.; Gao, Q.-H.; Wu, A.-X., Eds.; The Applications of DMSO.
2017; Chapter 7, pp 315−353. (b) Jones-Mensah, E.; Karki, M.;
Magolan, J. Synthesis 2016, 48, 1421−1436. (c) Wu, X.-F.; Natte, K.
Adv. Synth. Catal. 2016, 358, 336−352.
(12) For selected examples on DMSO-mediated reactions, for
thiomethylation, see: (a) Chu, L.; Yue, X.; Qing, F. L. Org. Lett. 2010,
12, 1644−1647. (b) Sharma, P.; Rohilla, S.; Jain, N. J. Org. Chem.
2015, 80, 4116−4122. (c) Liu, F.-L.; Chen, J.-R.; Zou, Y.-Q.; Wei, Q.;
Xiao, W.-J. Org. Lett. 2014, 16, 3768−3771. For methylenation, see:
(d) Patel, O. P. S.; Anand, D.; Maurya, R. K.; Yadav, P. P. J. Org.
Chem. 2016, 81, 7626−7634. (e) Zhang, Q.; Cai, S.; Li, L.; Chen, Y.;
Rong, H.; Niu, Z.; Liu, J.; He, W.; Li, Y. ACS Catal. 2013, 3, 1681−
1684. For methylsulfonylation, see: (f) Zhang, J.; Cheng, S.; Cai, Z.;
Liu, P.; Sun, P. J. Org. Chem. 2018, 83, 9344−9352. (g) Wen, Z.-K.;
Liu, X.-H.; Liu, Y.-F.; Chao, J.-B. Org. Lett. 2017, 19, 5798−5801. For
one-carbon synthon, see: (h) Xie, C.; Zhang, Z.; Li, D.; Gong, J.; Han,
X.; Liu, X.; Ma, C. J. Org. Chem. 2017, 82, 3491−3499 and references
cited therein .
(13) For DMSO/HX-mediated reactions, for HBr, see: (a) Majetich,
G.; Hicks, R.; Reister, S. J. Org. Chem. 1997, 62, 4321−4326.
(b) Floyd, M. B.; Du, M. T.; Fabio, P. F.; Jacob, L. A.; Johnson, B. D.
J. Org. Chem. 1985, 50, 5022−5027. For HCl, see: (c) Dotsenko, V.
V.; Krivokolysko, S. G. Chem. Heterocycl. Compd. 2013, 49, 636−644.
(14) Kokuev, A. O.; Antonova, Y. A.; Dorokhov, V. S.; Golovanov, I.
S.; Nelyubina, Y. V.; Tabolin, A. A.; Sukhorukov, A. Y.; Ioffe, S. L. J.
Org. Chem. 2018, 83, 11057−11066.
(15) Gao, X.; Pan, X.; Gao, J.; Huang, H.; Yuan, G.; Li, Y. Chem.
Commun. 2015, 51, 210−212.
(16) For 9a, see: (a) Zhu, X.; Wang, Y.-F.; Ren, W.; Zhang, F.-L.;
Chiba, S. Org. Lett. 2013, 15, 3214−3217. (b) Griesbeck, A. G.;
Franke, M.; Neudorfl, J.; Kotaka, H. Beilstein J. Org. Chem. 2011, 7,
127−134.
(17) For 9a-1, see: (a) Xue, L.-L.; Cheng, G.; Zhu, R.; Cui, X. RSC
Adv. 2017, 7, 44009−44012. (b) Liu, W.; Tan, H.; Chen, C.; Pan, Y.
Adv. Synth. Catal. 2017, 359, 1594−1598.
(18) For 9b, see: (a) Pusch, S.; Opatz, T. Org. Lett. 2014, 16, 5430−
5433. For 9b-1, see: (b) Tang, S.; He, J.; Sun, Y.; He, L.; She, X. Org.
Lett. 2009, 11, 3982−3985.
(19) For; Too, P. C.; Wang, Y.-F.; Chiba, S. Org. Lett. 2010, 12,
5688−5691.
(20) For examples on synthesis of quinoxalines, see: (a) Yang, Y.;
Zhang, S.; Wu, B.; Ma, M.; Chen, X.; Qin, X.; He, M.; Hussain, S.;
Jing, C.; Ma, B.; Zhu, C. ChemMedChem 2012, 7, 823−835.
(b) Schmidt, B.; Krehl, S.; Hauke, S. J. Org. Chem. 2013, 78,
5427−5435. (c) Go, A.; Lee, G.; Kim, J.; Bae, S.; Lee, B. M.; Kim, B.
H. Tetrahedron 2015, 71, 1215−1226. (d) Martin, L. J.; Marzinzik, A.
L.; Ley, S. V.; Baxendale, I. R. Org. Lett. 2011, 13, 320−323.
(e) Wang, W.; Shen, Y.; Meng, X.; Zhao, M.; Chen, Y.; Chen, B. Org.
E
Org. Lett. XXXX, XXX, XXX−XXX